Sean P. David
Brown Medical School/Memorial Hospital of Rhode Island
Pawtucket
USA
Name/email consistency: high
- Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. David, S.P., Munafò, M.R., Murphy, M.F., Proctor, M., Walton, R.T., Johnstone, E.C. Pharmacogenomics J. (2008)
- Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. David, S.P., Johnstone, E.C., Murphy, M.F., Aveyard, P., Guo, B., Lerman, C., Munafò, M.R. Drug. Alcohol. Depend (2008)
- Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. David, S.P., Brown, R.A., Papandonatos, G.D., Kahler, C.W., Lloyd-Richardson, E.E., Munafò, M.R., Shields, P.G., Lerman, C., Strong, D., McCaffery, J., Niaura, R. Nicotine Tob. Res. (2007)
- Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. David, S.P., Strong, D.R., Munafò, M.R., Brown, R.A., Lloyd-Richardson, E.E., Wileyto, P.E., Evins, E.A., Shields, P.G., Lerman, C., Niaura, R. Nicotine Tob. Res. (2007)
- The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. David, S.P., Munafò, M.R., Murphy, M.F., Walton, R.T., Johnstone, E.C. Nicotine Tob. Res. (2007)
- Building a successful research enterprise in family medicine: the Brown experience. David, S.P., Eaton, C.B., Culpepper, L., Goldman, R.E., Lavallee, L.K., Simmons, E.M. Med. Health. R. I (2006)
- Opioid antagonists for smoking cessation. David, S., Lancaster, T., Stead, L.F., Evins, A.E. Cochrane. Database. Syst. Rev (2006)
- Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. David, S.P., Munafò, M.R., Johansen-Berg, H., Smith, S.M., Rogers, R.D., Matthews, P.M., Walton, R.T. Biol. Psychiatry (2005)
- Pharmacogenetics. David, S.P. Prim. Care (2004)
- Envisaging and applying a unifying three-dimensional theoretical framework for generalist physicians. David, S.P., Eaton, C.B., Taylor, J.S., Stamp, M.J., Cyr, M., Siegel, B., Gramling, R., Walton, R. Med. Health. R. I (2004)
- Should we offer routine breast cancer screening with mammography?. David, S.P. Am. Fam. Physician (2003)
- Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?. David, S.P., Niaura, R., Papandonatos, G.D., Shadel, W.G., Burkholder, G.J., Britt, D.M., Day, A., Stumpff, J., Hutchison, K., Murphy, M., Johnstone, E., Griffiths, S.E., Walton, R.T. Nicotine Tob. Res. (2003)
- No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. David, S.P., Johnstone, E., Griffiths, S.E., Murphy, M., Yudkin, P., Mant, D., Walton, R. Pharmacogenetics (2002)
- Should we use multiple risk factor interventions for the primary prevention of coronary heart disease?. David, S.P. Am. Fam. Physician (2002)
- Should we prescribe antibiotics for acute conjunctivitis?. David, S.P. Am. Fam. Physician (2002)
- Media advocacy for the office-based teacher of family medicine. David, S.P. Fam. Med (2001)
- Should we recommend nicotine replacement therapy?. David, S.P. Am. Fam. Physician (2001)
- Opioid antagonists for smoking cessation. David, S., Lancaster, T., Stead, L.F. Cochrane. Database. Syst. Rev (2001)
- Reflections from a rotation in Cambridge, England. David, S.P. Fam. Med (2000)